Recital 5, Regulation (EU) 2020/1755

In forcesince 24 Nov 2020

The assessment of the preparation of Bacillus coagulans DSM 32016 shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of the product should be authorised as specified in the Annex to this Regulation.